The antithrombotic jungle : an overview of the recent literature
Physicians encounter patients who use antithrombotics in virtually every area of medical specialisation. As antithrombotic use is often chronic, it is important for medication monitoring that physicians have sufficient knowledge of the latest developments, even if they do not prescribe antithrombotics themselves. The risk of thrombosis must be weighed against the risk of bleeding in every patient who is eligible to be treated with antithrombotics. In this article we describe the main indications for treatment with antithrombotics based on articles published within the past five years.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:163 |
|---|---|
| Enthalten in: |
Nederlands tijdschrift voor geneeskunde - 163(2019) vom: 07. Nov. |
| Sprache: |
Niederländisch |
|---|
| Weiterer Titel: |
Oerwoud van antitrombotica: een overzicht van recente literatuur |
|---|
| Beteiligte Personen: |
Geersing, Geert-Jan [VerfasserIn] |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 22.05.2020 Date Revised 22.05.2020 published: Electronic Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM30353379X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM30353379X | ||
| 003 | DE-627 | ||
| 005 | 20231225113026.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||dut c | ||
| 028 | 5 | 2 | |a pubmed24n1011.xml |
| 035 | |a (DE-627)NLM30353379X | ||
| 035 | |a (NLM)31750636 | ||
| 035 | |a (PII)D4265 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a dut | ||
| 100 | 1 | |a Geersing, Geert-Jan |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The antithrombotic jungle |b an overview of the recent literature |
| 246 | 3 | 3 | |a Oerwoud van antitrombotica: een overzicht van recente literatuur |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.05.2020 | ||
| 500 | |a Date Revised 22.05.2020 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Physicians encounter patients who use antithrombotics in virtually every area of medical specialisation. As antithrombotic use is often chronic, it is important for medication monitoring that physicians have sufficient knowledge of the latest developments, even if they do not prescribe antithrombotics themselves. The risk of thrombosis must be weighed against the risk of bleeding in every patient who is eligible to be treated with antithrombotics. In this article we describe the main indications for treatment with antithrombotics based on articles published within the past five years | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 7 | |a Fibrinolytic Agents |2 NLM | |
| 700 | 1 | |a Greving, Jacoba P |e verfasserin |4 aut | |
| 700 | 1 | |a Folkeringa, Richard |e verfasserin |4 aut | |
| 700 | 1 | |a Hemels, Martin E W |e verfasserin |4 aut | |
| 700 | 1 | |a Ten Cate, Hugo |e verfasserin |4 aut | |
| 700 | 1 | |a Huisman, Menno V |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nederlands tijdschrift voor geneeskunde |d 1946 |g 163(2019) vom: 07. Nov. |w (DE-627)NLM000034231 |x 1876-8784 |7 nnns |
| 773 | 1 | 8 | |g volume:163 |g year:2019 |g day:07 |g month:11 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 163 |j 2019 |b 07 |c 11 | ||